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Lead in Bone: Sampling and Quantitation
Using K X-Rays Excited by 109Cd
by D. R. Chettle,* M. C. Scott,* and L. J. Somervaille*
Lead inbone can be measured in vivo using -y-rays from a l09Cd source to excite lead K X-rays. Nor-
malization of lead X-ray amplitudes to that ofthe elastically backscattered 88 keV y-rays produces
adetermination ofthe concentration ofleadinbonemineral that isaccurate andinsensitive to varia-
tions in measurement or bone geometry. For in vivo tibia measurements, a typical precision (1 SD)
of ± 5 ,g lead (g bone mineral)-' is achieved for an effective dose equivalent of 2.1 tSv. Measure-
ment can be made ofany superficial bone site, but precision will vary approximately as the inverse
of the square root of the mass ofbone mineral sampled. The apparatus required for this technique
is readily transportable, and mobile laboratory facilities are easily established.
Introduction
The noninvasive measurement ofbone lead humans
was first reported by Ahlgren et al. in 1976 (1). Their
X-ray fluorescence system used 'y-rays from 57Co to ex-
cite the K series X-rays oflead. Thisapproach has been
further developed(2,3) and adopted elsewhere (4). Sub-
sequently, an alternative approach, which used '09Cd
rather than 57Co to excite lead K-series X-rays, was
proposed(5)anddeveloped(6,7). A substantially differ-
ent methodology, while still being X-ray fluorescence,
has been employed in measuring bone lead by means
oftheL-series X-rays,usingeitherradioisotope sources
(8,9) or polarized X-rays (10) as the incident radiation.
It is the use of '09Cd to excite lead K-series X-rays that
will be considered here, as this approach has consider-
able flexibility in being able to sample lead in a range
ofdifferentbone sites and arobust normalization tech-
nique, which obviates the need to correct for bone ge-
ometry, thickness ofoverlyingtissue, andotherfactors.
109Cd Technique for K X-Ray
Fluorescence of Lead
The equipment used in these measurements is
shown schematically in Figure 1. '09Cd emits ay-rays of
88.035 keV, just above the 88.005 keV K-shell absorp-
tion edge in lead, in 3.6% ofits decays; it also emits sil-
ver K X-rays of22 or 25 keV with an intensity 25 to 30
timeshigher. These silver X-rays are filtered outby 0.5
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mm ofcopper in front ofthe source, which has little ef-
fectonthe intensity of88keV'y-rays. Theay-rays canin-
teract with a K-shell electron in lead, ejecting it with
theresultingvacancybeingfilledbylesstightlybound
electrons and energybeingreleased as K-series X-rays
(96% oftransitions) or Auger electrons.
In addition, Compton scattering of incident a-rays
can occur inthe subject, resultingin scatteredphotons
ofreduced energy, the energy depending on the angle
ofscatter. Inthiscase(Fig. 1), themeanangle ofscatter
is a little over 1500, and the corresponding energy of
Compton-scattered photons is 66.5 keV. A large angle
of scatter is an essential feature ofthe use of109Cd to
measure lead because the Compton-scatter peak is
then well below the X-ray peaks; for example, were a
900 scattering angle used, this would result in Comp-
ton-scatteredphotonsof75.1 keV,whichwouldobscure
the lead Ka X-rays.
Elastic scattering, the remaining important process
characterizing this technique, results in a scattered
photon, essentially of unchanged energy; the photon
direction is usually only slightly altered but occasion-
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FIGURE 1. Equipment for K X-ray fluorescence of lead using "'Cd.50
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FIGURE 2. (A) Photon energy spectrum of tibia of a lead worker, estimated to have 123 yg lead (g bone mineral)-'. (B) Expanded spectrum
showing regions fitted for quantitation.
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ally is changedby the large angles usedforthese mea-
surements. A photon energy spectrum from a tibia
measurement of a lead worker (Fig. 2) shows that
Compton scattering isthe dominant contributor tothe
observed spectrum, although the elastically scattered
88 keV peak is also clearly visible. Also shown are the
three regions of the spectrum used for quantitating
data, viz, 70 to 78 keV (KcU2: 72.8 keV and Kce1: 75.0
keV), 82 to 86.5 keV (K03 : 84.5 keV and K31, 85.0
keV) and 86.6 to 89.5 keV (Kf32: 87.3 keV and elastic
scatter: 88 keV).
Elastic Scatter Normalization
As noted above, elastic scattering, particularly at
these large angles (-1500), is a low probability event
compared to Compton scattering. However, the cross-
section at this energy and angle varies very strongly
withthe atomicnumber(z)ofatarget atom. Thisvaria-
tion is illustrated in Figure 3 over a range ofelements
foundinhumantissue. Sincethecross-section depends
onthefifthorsixthpowerofz,theobservedelastic scat-
ter peak comes predominantly from the higher z ele-
mentspresent. Inthecaseofabone, suchastibiaorcal-
caneus, 98 to 99% of the elastic scatter signal arises
from the bone mineral, rather than other tissue com-
ponents. Two further factors are also pertinent to the
normalization process. First, the lead X-ray signal also
arisesfromthebone asthisistheprincipal storage site
for lead andno subsidiary storage site, such as liver or
kidney, is likely to be in view during a bone lead mea-
surement. Also, although lead concentration in bone
has been shown to vary sharply over distances ofthe
order of 100 itm (11), it is effectively uniformly distri-
buted on the integrated scale defined by the penetra-
tionofleadKX-rays(-30 mm). Second, effectively, only
uncollided incident ay-rays can produce lead K X-rays
because the 88.035 keV y-rays from '09Cd are only
some 30 eV above the lead K absorption edge. Thus it
is the same photon fluence that gives rise to both the
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FIGURE 3. Elastic scatter cross-section at 88 keV and 1500 as a func-
tion of atomic number.
elastic scatter peak and the lead K X-ray peaks.
The combination ofthese threefactorsproduces a ro-
bust normalization of lead to bone mineral when the
ratio is taken ofthe amplitudes oflead K X-rays to the
elastic scatter peak. The effectiveness ofthis normal-
ization procedure is shown by Figure 4, which shows
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FIGURE 4. Elastic scatter normalization. (A) Source to sample distance; (B) thickness of overlying tissue.
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TIble 1. Elastic scatter cross-sections for
bone mineral and plaster of Paris.
Elastic scatter, gm2 g-1
1400 153.250a 1700
Bone mineral 7677 7420 7283
Plaster of Paris 5285 5082 4983
Correction factor 1.453 1.460 1.462
a Mean scattering angle for system shown in Figure 1.
how the ratio oflead X-ray to elastic amplitude is in-
sensitive to either source to sample distance or thick-
ness ofoverlying tissue, despite marked variations in
lead X-ray counts alone.
The X-ray to elastic ratio observed in bones is cali-
brated against plaster ofParis (calcium sulfate) phan-
tomsdopedwithknownquantities oflead. Acorrection
thenhastobemadetoallowforthedifference inelastic
scattering cross-section between plaster of Paris and
bone mineral. The cross-sections have been interpo-
lated from the tabulated data of Hubbell and Overbo
(12). Ascanbe seenfromTable 1, the cross-sections are
a weakly varying function ofangle, so the fact that a
range ofangles is subtended in any measurement sys-
tem is unlikely to distort the normalization; thus, the
mean scattering angle in a particular measurement
geometry can be used.
Quantitation, Precision, and Dose
Although the lead Ka, and Ka2 X-rays are the most
intense, the background underlying the Kf31 and K,3
is so much less that they can still contribute usefully
to the overall precision. However, in order to extract
data from the Kfl,,3 peaks, account must be taken of
the feature at 84.0 keV, which is an edge marking the
upper end of the bremsstrahlung spectrum of photo-
electrons ejected fromthe K shell ofcalcium by the 88
keV -y-rays (13). There are less prominent, but analo-
gousfeatures, at 85.9 keVfromphosphorus, inthe case
ofbonemineral, andat85.6keVfromsulfur, inthecase
of plaster of Paris. The lead Kj32 line, although used
for in vitroanalyses, is not usedfor in vivo analyses be-
cause there is an oxygen photoelectron bremsstrah-
lung edge that interferes with it. The height of this
latter feature varies with the amount of soft tissue
overlying and surrounding the bone.
The measurement precision, although not the ac-
curacy, varies somewhat from person to person, de-
pending onfactors such asthe amount ofoverlying tis-
sue andthe mass ofbone mineral sampled. In atypical
field survey of in vivo tibia lead measurements, the
standard deviation on an individual measurement (gi)
varies from about ± 3.5 to ± 10.0 itg lead (g bone min-
eral)-' for a skin dose of 0.5 mGy. The corresponding
root mean square standard deviation, that is,
[ (i= )/
- ½/2
Table 2. Contribution of different
K X-ray peaks to precision.
SD for analysis based
on different X-rays,
X-rays Relative intensity yig (g bone mineral)'
Kai 1.0 6.6
Ka2 0.593 17.0
Ko1 0.228 9.9
K,B3 0.119 17.7
Ka,, + Ko,2 (1.0 + 0.593) 6.2
K3, + K3 (0.228 + 0.119) 8.6
Ka1,2 + Kj313 (1.0 + 0.593 + 0.228 + 0.119) 5.0
is 5.0 jig lead (g bone mineral)-'. The contributions of
the different K X-rays to the overall precision are sum-
marizedinTable 2,fromwhichitcanbe seenthatanal-
ysis ofKa, alone would result in a precision of ± 6.6
yg lead (g bone mineral)-' and that this figure is re-
duced to 5.0itg lead (g bone mineral)-' when the other
peaks are also analyzed. A practical detection thres-
hold for lead in tibia can then be taken to be 10 jg (g
bone mineral)-'. In adult tibia this equates to 5.6 itg
lead (g wet bone)-'; however, results are more conve-
niently quoted with respect to bone mineral as this re-
flects the normalization process and enables straight-
forwardcomparisonbetweenbones,withnoassumptions
having to be made about bone mineral density.
The effective (whole body) dose equivalent of2.1 ySv
is low and can be put in context by comparison to nat-
ural background radiation. Such exposures vary from
place to place but are often in the range of2 to 3 mSv
per year. Thus, the dose delivered during a bone lead
measurement is approximately equivalent to 6 to 9 hr
of natural background radiation.
Comparisons between X-Ray
Fluorescence and Atomic Absorption
Spectroscopy
In order to validate the '09Cd K X-ray fluorescence
technique for bone lead measurements, sets of bone
sampleshavebeenanalyzedbothby atomicabsorption
spectroscopy andbyX-rayfluorescence. Atomicabsorp-
tion spectroscopy measurements were performed by
Wittmers et al. inthe mannerthey have described pre-
viously (14). The samples used were about 20 mg of
bone mineral and were removed prior to the samples
being analyzed by X-ray fluorescence. The X-ray fluo-
rescence technique sampled up to 10 to 15 g of bone
mineral, less in the case oftibia fragments. Thus, the
masses of the bones sampled by the two techniques
were significantly different. The data comparing the
two measurement techniques have been reported pre-
viously (15,16) and are summarized in Table 3. Table 3
shows the mean differences between X-ray fluores-
cence and atomic absorption measurements, their
standard deviation, and the reduced x2 statistics, as a
testofobservedvariance ofthe differencescomparedto
their pooled measurement variances.
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Ibble 3. Comparison of X-ray fluorescence (XRF)
and atomic absorption (AA) results.
Mean (XRF-AA) ±SD,
Bone sample n Fg lead (g bone mineral)-' x2
Metatarsal 6 -3.4 ± 4.1 0.43
Tibia section 3 4.9 ± 4.3 0.74
Tibia section 16 1.0 ± 7.6 4.36
Tibia section 22 -1.0 ± 9.9 3.92
Tibia fragment 11 -3.0 ± 6.2 1.93
Calcaneus 22 2.0 ± 23.7 5.66
Combined sets
Tibia section 41 0.2 ± 8.8 3.90
All bones 80 0.0 ± 14.1 4.01
There is clearly no evidence for a systematic differ-
ence in the results obtained by the two different tech-
niques, anditisunlikelythatadifference ofmorethan
3jg lead(gbone mineral)-' could exist. The x2 is high-
ly significant, indicating that there is greaterrandom
variation between the measurements than that pre-
dicted by the known measurement precisions of the
twotechniques. It isprobable that atleastsome ofthis
increased variance is associated with the different
masses ofbones sampled.
Sampling Different Bone Sites
The '09Cd K X-ray fluorescence technique has been
used to sample different bone sites, principally tibia
and calcaneus, although other bones have been mea-
sured inindividuals andonsurveys. The initialreason
for measuring more than one bone site was to sample
differing types ofbone, the midshaft ofthe tibia being
largely cortical, while the calcaneus is trabecular
apartfromathin cortical sheath. Rather surprisingly,
the correlationbetween calcaneus andtibia in a cross-
sectional survey, which included retired as well as
active lead workers, was very strong (r = 0.893, n =
112) (17). This relationship is illustrated in Figure 5.
One importantfactor indecidingonwhichbone sites
to sample is the precision that will be obtained on the
measurements. Precision depends onthe mass ofbone
mineral sampled, the amount oftissue overlying the
bone, and the geometry ofthe measurement. The re-
sulting wide differences in the height of the elastic
scatter peak are illustrated by Figure 6, which shows
these portions of spectra from measurements at four
different bone sites onthe same person. Theprecision,
which varies inverselywiththe square rootofthe area
ofthe elastic scatter peak, ranged from ± 4.1 itg lead
(g bone mineral)-' for a tibia measurement to ± 23.2
Fg lead (g bone mineral)-' for a rib measurement.
A second important factor in choosing a bone site is
the degree to which it might be representative ofthe
entire bone mass in the body. Wittmers et al. (18) ex-
aminedfive differentbone sites at autopsy in 134 peo-
ple covering ages 0 to 98 years and concluded that of
tibia, vertebra, rib, ilium, and skull, the tibia best re-
flected estimated total skeletal lead burden over the
wide range ofages. In addition, in vivo tibia lead data
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FIGURE 5. Calcaneus lead versus tibia lead in a cross-sectional
survey.
havebeenshowntoreflectcumulativeexposureinthat
they correlate closely with an index ofblood lead in-
tegratedoveraworker'soccupational exposurehistory
(19).
The apparatus required for measuring bone lead by
the '"Cd K X-ray techniques is notbulky and isthere-
fore easily transported, for example, to a factory site.
We have conducted surveys at different sites within
England,Sweden,andFinlandandsimultaneousmea-
surementshavebeenmade ofmorethan onebone(Fig.
7). Figure 7 shows aworkerbeingmeasuredin our car-
avan, equipped as a mobile laboratory.
Conclusions
The '09Cdtechnique for K X-ray fluorescence oflead
has been clearly demonstrated to be a practical and
convenient way ofmonitoring lead stores in the body.
The use ofthe elastic scatter normalization makesthe
measurement robust, in that it is insensitive to geo-
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metrical variations, and accurate as an assessment of
%m >_ v lead concentration with respect to bone mineral.
Quantitation based onfourX-raysyields aprecision of
; 5 jig lead(g bone mineral)-' for a very low effective
dose equivalent of 2.1 itSv. The accuracy of the tech-
nique has been confirmed by intercomparison with
atomic absorption spectroscopy. These points combine
to underline that this methodology has many attrac-
i 2; 0> tions for use inthe study ofexposure to lead and itsbe-
havior in the body.
2] _05_ X 0\ W If a single bone site is to be monitored to obtain an
assessment of skeletal lead burden, then tibia is the
preferred site. There remains, however, considerable
interest in the comparative lead levels in different
bone types and, in this context, calcaneus may be the
best available way of monitoring a trabecular bone
with an in vivo measurement. This area ofbone lead
metabolismclearly requiresfurtherwork. It shouldbe
FIGURE 7. Simultaneous in vivo bone lead measurements oftibia noted that this technique has not yet been applied to
anc calcaneus.
54MEASURING BONE LEAD USING K X-RAYS EXCITED BY '09Cd 55
studies ofchildhood lead exposure. In appropriate cir-
cumstances, there is every reason to expect it to yield
valuable and quantitatively reliable information, but
the precision obtained inmeasuring achild'stibiawill
be worse than that for an adult because the mass of
bone mineral sampled will be considerably less. Also,
interpretation of such data would be more complex
than for adult studies, as a smaller and more variable
proportion of a child's lead body burden is found in
bone (20). Finally, it should be noted that these bone
lead measurements can be conducted from a mobile
facility, making it relatively convenient to conduct
field surveys.
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